Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
MUC2
REST API REST API
Homo sapiens
MUC2 is differentially expressed in 139 experiments: 57 organism parts: skeletal muscle, colon, ... (55 more);, 71 disease states: normal, colon carcinoma, ... (69 more);, 39 cell types 104 cell lines 12 compound treatments and 60 other conditions.
Orthologs MUC2 (Gallus gallus)   Muc2 (Mus musculus)   MUC2 (Canis familiaris)   ENSXETG00000018933 (Xenopus laevis)   ENSXETG00000033313 (Xenopus laevis)   ENSXETG00000033075 (Xenopus laevis)   ENSXETG00000009936 (Xenopus laevis)   ENSXETG00000009949 (Xenopus laevis)   ENSXETG00000006096 (Xenopus laevis)   muc2 (Xenopus laevis)   ENSXETG00000015921 (Xenopus laevis)   ENSXETG00000032037 (Xenopus laevis)   ENSXETG00000019487 (Xenopus laevis)   ENSXETG00000014892 (Xenopus laevis)   XB-GENE-5761342 (Xenopus laevis)   LOC100498067 (Xenopus laevis)   ENSXETG00000025761 (Xenopus laevis)   (Compare orthologs)
InterPro Term Cys_knot_C, VWF_C, Prot_Inh_CR_TIL, VWC_out, VWF_type-D, Unchr_dom_Cys-rich
Gene Ontology Term protein binding, apoptosis, negative regulation of cell proliferation, proteinaceous extracellular matrix, induction of apoptosis, negative regulation of cell migration
UniProt Accession Q9UMI9, Q9HBC6, Q02817, E7EUV1
Search EB-eye ENSG00000198788
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-AFMX-5, E-MTAB-24, E-MTAB-25, ... (18 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-22639, E-GEOD-19639, E-GEOD-29119, E-GEOD-24147, E-GEOD-19480, ... (15 experiments)

Factor Value U/D Experiments
SNU16
2
 E-MTAB-37, E-GEOD-15460
LC2/ad
1
 E-MTAB-62
GM15036
1
 E-GEOD-22639
HCC1954
1
 E-GEOD-29119
Calu6
1
 E-MTAB-37
H720
1
 E-GEOD-3202
98 more value(s).


Cell type

studied in E-GEOD-22373, E-GEOD-3920, E-GEOD-13987, E-GEOD-11755, E-GEOD-21909, ... (26 experiments)

Factor Value U/D Experiments
monocyte
1
2
 E-GEOD-22373, E-GEOD-8286, E-GEOD-11755
breast cancer
1
 E-GEOD-29119
vascular smooth muscle cell
1
 E-TABM-130
hematopoietic stem cell
1
 E-MEXP-1403
M1 macrophage
1
 E-GEOD-5099
n/a
1
 E-MTAB-24
33 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-2466, E-MEXP-882, E-GEOD-1869, ... (30 experiments)

Factor Value U/D Experiments
normal
6
7
 E-GEOD-15960, E-GEOD-6338, E-TABM-276, E-GEOD-23878, E-GEOD-5390, ... (13 experiments)
non-ischemic cardiomyopathy
1
 E-GEOD-1869
cystic fibrosis
1
 E-MTAB-62
lung cancer, cytotoxicity
1
 E-MTAB-62
follicular thyroid adenoma
1
 E-MTAB-62
endometriosis
1
 E-GEOD-7307
65 more value(s).


Compound treatment

studied in E-GEOD-5258, E-GEOD-412, E-MEXP-1335, E-GEOD-6400, E-GEOD-5099, ... (9 experiments)

Factor Value U/D Experiments
glutamine
2
 E-MEXP-1335, E-MEXP-941
control
30
1
 E-GEOD-995
actinomycin D
1
1
 E-GEOD-6400
hydrogen peroxide
2
1
 E-GEOD-5339
nocodazole
1
 E-GEOD-5258
none
2
1
 E-GEOD-412, E-GEOD-995, E-GEOD-7307
6 more value(s).


Age at diagnosis

studied in E-GEOD-3494, E-GEOD-21653

Factor Value U/D Experiments
58
1
1
 E-GEOD-21653
86
1
 E-GEOD-3494


Agent
studied in E-GEOD-19519

Biopsy tissue
studied in E-GEOD-5851

Biosource provider
studied in E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Clinical history
studied in E-GEOD-19420, E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, ... (6 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-GEOD-21589, E-GEOD-16363, ... (6 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-3140, E-GEOD-4667, E-MTAB-62

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743

Environmental stress
studied in E-GEOD-1643

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genotype
studied in E-GEOD-2466, E-TABM-321, E-MEXP-1403

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-MEXP-1446

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-GEOD-21653, E-TABM-276, E-GEOD-20194, E-GEOD-16716

Individual
studied in E-MTAB-197, E-TABM-176, E-MEXP-2069, E-GEOD-1926, E-GEOD-19519, ... (19 experiments)

Infection
studied in E-GEOD-2405, E-GEOD-12254

Injury
studied in E-GEOD-19743

Material type
studied in E-MEXP-455

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-1801, E-TABM-84

Organism status
studied in E-GEOD-19188

Performer
studied in E-GEOD-2004

Phenotype
studied in E-GEOD-5824, E-GEOD-5820

Population
studied in E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246, E-GEOD-1343 ... (5 experiments)

Qpcr egfr dct
studied in E-GEOD-5851

Qrt pcr areg dct
studied in E-GEOD-5851

RNAi
studied in E-MEXP-101, E-GEOD-3697

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374

Sex
studied in E-GEOD-2466

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-4922, E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-GEOD-1926, E-TABM-276

Treatment
studied in E-GEOD-22152, E-GEOD-16837, E-GEOD-19246

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor size
studied in E-GEOD-6532

Vehicle
studied in E-GEOD-5258

Processing time: 0.562 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM